Incorporating historical control information in ANCOVA models using the meta-analytic-predictive approach

被引:3
|
作者
Qi, Hongchao [1 ,2 ]
Rizopoulos, Dimitris [1 ,2 ]
van Rosmalen, Joost [1 ,2 ]
机构
[1] Erasmus MC, Dept Biostat, Doctor Molewaterpl 40, NL-3015 GD Rotterdam, Netherlands
[2] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands
关键词
analysis of covariance (ANCOVA); Bayesian statistics; historical borrowing; meta-analytic-predictive (MAP); PARTICIPANT DATA METAANALYSES; PLACEBO-CONTROLLED TRIAL; ALZHEIMER-DISEASE; CLINICAL-TRIALS; PRIOR DISTRIBUTIONS; COGNITIVE DECLINE; DOUBLE-BLIND; SAMPLE-SIZE; SUPPLEMENTATION; RESVERATROL;
D O I
10.1002/jrsm.1561
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The meta-analytic-predictive (MAP) approach is a Bayesian meta-analytic method to synthesize and incorporate information from historical controls in the analysis of a new trial. Classically, only a single parameter, typically the intercept or rate, is assumed to vary across studies, which may not be realistic in more complex models. Analysis of covariance (ANCOVA) is often used to analyze trials with a pretest-posttest design, where both the intercept and the baseline effect (coefficient of the outcome at baseline) affect the estimated treatment effect. We extended the MAP approach to ANCOVA, to allow for variation in the intercept and the baseline effect across studies, and possibly also correlation between these parameters. The method was illustrated using data from the Alzheimer's Disease Cooperative Study (ADCS) and assessed with a simulation study. In the ADCS data, the proposed multivariate MAP approach yielded a prior effective sample size of 79 and 58 for the intercept and the baseline effect respectively and reduced the posterior standard deviation of the treatment effect by 12.6%. The result was robust to the choice of prior for the between-study variation. In the simulations, the proposed approach yielded power gains with a good control of the type I error rate. Ignoring the between-study correlation of the parameters or assuming no variation in the baseline effect generally led to less power gain. In conclusion, the MAP approach can be extended to a multivariate version for ANCOVA, which may improve the estimation of the treatment effect.
引用
收藏
页码:681 / 696
页数:16
相关论文
共 50 条
  • [1] Robust Meta-Analytic-Predictive Priors in Clinical Trials with Historical Control Information
    Schmidli, Heinz
    Gsteiger, Sandro
    Roychoudhury, Satrajit
    O'Hagan, Anthony
    Spiegelhalter, David
    Neuenschwander, Beat
    [J]. BIOMETRICS, 2014, 70 (04) : 1023 - 1032
  • [2] Modified Robust Meta-Analytic-Predictive Priors for Incorporating Historical Controls in Clinical Trials
    Zhao, Qiang
    Ma, Haijun
    [J]. STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2024, 16 (02): : 241 - 247
  • [3] Borrowing historical information to improve phase I clinical trials using meta-analytic-predictive priors
    Chen, Xin
    Zhang, Jingyi
    Jiang, Qian
    Yan, Fangrong
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2022, 32 (01) : 34 - 52
  • [4] Bayesian semiparametric meta-analytic-predictive prior for historical control borrowing in clinical trials
    Hupf, Bradley
    Bunn, Veronica
    Lin, Jianchang
    Dong, Cheng
    [J]. STATISTICS IN MEDICINE, 2021, 40 (14) : 3385 - 3399
  • [5] The network meta-analytic-predictive approach to non-inferiority trials
    Schmidli, Heinz
    Wandel, Simon
    Neuenschwander, Beat
    [J]. STATISTICAL METHODS IN MEDICAL RESEARCH, 2013, 22 (02) : 219 - 240
  • [6] Addressing prior-data conflict with empirical meta-analytic-predictive priors in clinical studies with historical information
    Li, Judy X.
    Chen, Wei-Chen
    Scott, John A.
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2016, 26 (06) : 1056 - 1066
  • [7] Meta-analytic-predictive use of historical variance data for the design and analysis of clinical trials
    Schmidli, Heinz
    Neuenschwander, Beat
    Friede, Tim
    [J]. COMPUTATIONAL STATISTICS & DATA ANALYSIS, 2017, 113 : 100 - 110
  • [8] Elastic meta-analytic-predictive prior for dynamically borrowing information from historical data with application to biosimilar clinical trials
    Zhang, Wen
    Pan, Zhiying
    Yuan, Ying
    [J]. CONTEMPORARY CLINICAL TRIALS, 2021, 110
  • [9] Sample size calculation for clinical trials analyzed with the meta-analytic-predictive approach
    Qi, Hongchao
    Rizopoulos, Dimitris
    van Rosmalen, Joost
    [J]. RESEARCH SYNTHESIS METHODS, 2023, 14 (03) : 396 - 413
  • [10] Applying Meta-Analytic-Predictive Priors with the R Bayesian Evidence Synthesis Tools
    Weber, Sebastian
    Li, Yue
    Seaman, John W., III
    Kakizume, Tomoyuki
    Schmidli, Heinz
    [J]. JOURNAL OF STATISTICAL SOFTWARE, 2021, 100 (19): : 1 - 32